Stonepine Capital Management’s iTeos Therapeutics ITOS Stock Holding History

Stonepine Capital Management’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-310,033	Closed	-$3.09M	–	67
2025 Q2	$3.09M	Buy	310,033 +200,033	+182%	+$1.61M	3.03%	10
2025 Q1	$657K	Hold	110,000	–	–	0.64%	32
2024 Q4	$845K	Buy	110,000 +80,000	+267%	+$687K	0.68%	32
2024 Q3	$306K	Buy	+30,000	New	+$458K	0.19%	35

Other funds holding ITOS

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Stonepine Capital Management's ITOS Position: Q3 2025 in Review

Stonepine Capital Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 310,033 shares — an estimated $3.09M sold.

Stonepine Capital Management first reported a position in ITOS in Q3 2024 and held it in 4 quarters. The position peaked at $3.09M in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Stonepine Capital Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Stonepine Capital Management sold 310,033 iTeos Therapeutics shares in Q3 2025, an estimated $3.09M.
Stonepine Capital Management first reported a position in iTeos Therapeutics in Q3 2024 and held it in 4 quarters.
Stonepine Capital Management's iTeos Therapeutics position peaked at $3.09M in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Stonepine Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.